Condition
Injection Site Bruising
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Completed3
Withdrawn1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05577832Not ApplicableCompleted
Testing Different Methods of Intramuscular Injection
NCT05771285Not ApplicableCompletedPrimary
Cold Application on the Subcutaneous Injection
NCT04373603Phase 4WithdrawnPrimary
Use of Tranexamic Acid in Facial Fillers
NCT05109000Phase 4Unknown
Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline
NCT03645369Not ApplicableCompleted
Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection
Showing all 5 trials